An Adamantyl-Substituted Retinoid-Derived Molecule That Inhibits Cancer Cell Growth and Angiogenesis by Inducing Apoptosis and Binds to Small Heterodimer Partner Nuclear Receptor: Effects of Modifying Its Carboxylate Group on Apoptosis, Proliferation, and Protein-Tyrosine Phosphatase Activity

This publication has 78 references indexed in Scilit:

• Adamantyl-Substituted Retinoid-Related Molecules Bind Small Heterodimer Partner and Modulate the Sin3A Repressor
  Cancer Research, 2007
• Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt
  Oncogene, 2006
• SHP Represses Transcriptional Activity via Recruitment of Histone Deacetylases
  Biochemistry, 2005
• Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog
  Blood, 2002
• The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor α-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal β-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase
  Molecular and Cellular Endocrinology, 2001
• Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis
  International Journal of Cancer, 2000
• Activation of the p38 and JNK/SAPK Mitogen-Activated Protein Kinase Pathways during Apoptosis Is Mediated by a Novel Retinoid
  Experimental Cell Research, 1999
• Retinoic Acid Syndrome
  Drug Safety, 1998
• Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ
  Biochemical and Biophysical Research Communications, 1992
• Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl)]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids
  Journal of Medicinal Chemistry, 1983